BioLineRx (BLRX) Interest Coverage Ratio (2011 - 2026)
BioLineRx (BLRX) posted quarterly Interest Coverage Ratio of 1.49 for Q4 2025, down 34.21% year-over-year from 2.26 in Q4 2024, and down 120.46% quarter-over-quarter from 7.26 in Q3 2025.
Powered by 
Analysis
BioLineRx (BLRX) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
BioLineRx's Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 1.49 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio fell 34.21% year-over-year to 1.49; the TTM figure through Dec 2025 stood at 8.04 (down 125.16% YoY), while the FY2025 annual figure was 8.04, up 459.11% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 1.49, down from 7.26 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 32.68 in Q1 2022, with the low at 3.52 in Q4 2023.
- The 5-year median for Interest Coverage Ratio is 7.88 (2023), against an average of 12.25.
- The sharpest annual moves came in 2021 and 2023: Interest Coverage Ratio soared 291.48% in 2021, then sank 155.63% in 2023.
- BioLineRx's Interest Coverage Ratio stood at 32.34 in 2021, then tumbled by 80.42% to 6.33 in 2022, then sank by 155.63% to 3.52 in 2023, then surged by 68.59% to 1.11 in 2024, then sank by 34.21% to 1.49 in 2025.
- Business Quant data shows BLRX's Interest Coverage Ratio at 1.49 in Q4 2025, 7.26 in Q3 2025, and 8.34 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | -21.24 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 1.42 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 10 | BioLineRx | 6.53 Bn | 6.53 Bn | 235,000.00 | 17.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.18 |
| Mar 31, 2026 | 12.02 |
| Dec 31, 2025 | 12.09 |
| Sep 30, 2025 | 7.26 |
| Jun 30, 2025 | 8.34 |
| Mar 31, 2025 | 5.69 |
| Dec 31, 2024 | 0.99 |
| Sep 30, 2024 | 3.32 |
| Jun 30, 2024 | 2.77 |
| Mar 31, 2024 | 5.19 |
| Dec 31, 2023 | -19.92 |
| Sep 30, 2023 | 14.76 |
| Jun 30, 2023 | 7.42 |
| Mar 31, 2023 | 9.55 |
| Dec 31, 2022 | 6.33 |
| Sep 30, 2022 | 26.51 |
| Jun 30, 2022 | 20.06 |
| Mar 31, 2022 | 32.68 |
| Dec 31, 2021 | 32.34 |
| Sep 30, 2021 | 23.82 |